Please use this identifier to cite or link to this item: 10.3390/medicina59020340
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKustovs, Dmitrijs-
dc.contributor.authorUrtāne, Inga-
dc.contributor.authorSevostjanovs, Eduards-
dc.contributor.authorMoreino, Eva-
dc.contributor.authorTrušinskis, Kārlis-
dc.date.accessioned2023-02-14T10:45:01Z-
dc.date.available2023-02-14T10:45:01Z-
dc.date.issued2023-02-10-
dc.identifier.citationKustovs , D , Urtāne , I , Sevostjanovs , E , Moreino , E & Trušinskis , K 2023 , ' Opportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapy ' , Medicina , vol. 59 , no. 2 , 340 . https://doi.org/10.3390/medicina59020340-
dc.identifier.issn1010-660X-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/10366-
dc.descriptionFunding Information: The present study was part of the doctoral research program. The current doctoral research project was funded by the Riga Stradiņš University (Nr. 6-ZD-22/15/2021). The funder had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, or approval of the manuscript. Publisher Copyright: © 2023 by the authors.-
dc.description.abstractBackground and Objectives: Blood pressure measurement is essential evidence to establish that the chosen medicine and dosage are appropriate, and also indirectly indicates whether the medicine is being used at all. Therefore, current research compares adherence to the target blood pressure at home and in the hospital between different age groups, using similar combinations of the drugs prescribed by the doctor within ongoing antihypertensive therapy. Moreover, it is very important to develop a method for the determination of amlodipine and its metabolite, which would suitable for clinical applications, when the result is needed as quick as possible. Materials and Methods: This prospective study included patients aged ≥18 years who were diagnosed with hypertension. Subjects were divided into two age groups according to European Society of Cardiology (ESC) hypertension guidelines; older patients (≥65 years) and adult patients (en
dc.format.extent3254518-
dc.language.isoeng-
dc.relation.ispartofMedicina-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectamlodipine-
dc.subjectadherence-
dc.subjectdrug monitoring-
dc.subjectdehydro-amlodipine-
dc.subjecthypertension-
dc.subject3.2 Clinical medicine-
dc.subject3.1 Basic medicine-
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database-
dc.titleOpportunities of Amlodipine as a Potential Candidate in the Evaluation of Drug Compliance during Antihypertensive Therapyen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article-
dc.identifier.doi10.3390/medicina59020340-
dc.contributor.institutionDepartment of Pharmaceutical Chemistry-
dc.contributor.institutionDepartment of Internal Diseases-
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85148902823&partnerID=8YFLogxK-
dc.description.statusPeer reviewed-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Opportunities_of_Amlodipine.pdf3.18 MBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.